Human medicines European public assessment report (EPAR): Humalog, insulin lispro, Date of authorisation: 30/04/1996, Revision: 37, Status: Authorised

PSUSA/00002117/202511

PSUSA/00002829/202511

PSUSA/00003135/202512

Human medicines European public assessment report (EPAR): Abasaglar (previously Abasria), insulin glargine, Date of authorisation: 09/09/2014, Revision: 14, Status: Authorised

European platform for regulatory science research meeting: June 2026 , Online, from 16 June 2026, 14:00 (CEST) to 16 June 2026, 18:00 (CEST)

Template - Application for transfer of marketing authorisation from transferor to transferee - cover letter (human)

Guidance for applicants for the preparation of the precise scope section of the variation application form

Pre-notification check for type IB Variations

Pre-notification check for type IA/IAIN variations